164 related articles for article (PubMed ID: 28692546)
1. HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
Philibert P; Chiche L; Caillères S; Allemand J; Rebaudet S; Delord M; Stavris C; Retornaz F; Khiri H; Halfon P
AIDS; 2017 Sep; 31(15):2167-2169. PubMed ID: 28692546
[TBL] [Abstract][Full Text] [Related]
2. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
[TBL] [Abstract][Full Text] [Related]
3. Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen.
Bani-Sadr F; Fournier S; Molina JM
AIDS; 2003 Jul; 17(10):1580-1. PubMed ID: 12824806
[No Abstract] [Full Text] [Related]
4. Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study.
Martínez E; Larrousse M; Llibre JM; Gutiérrez F; Saumoy M; Antela A; Knobel H; Murillas J; Berenguer J; Pich J; Pérez I; Gatell JM;
AIDS; 2010 Jul; 24(11):1697-707. PubMed ID: 20467288
[TBL] [Abstract][Full Text] [Related]
5. Is switching protease inhibitor-based effective antiretroviral therapy safe in patients with AIDS-associated Kaposi's sarcoma?
Ridolfo AL; Corbellino M; Tosca N; Capelletti A; Scalamogna C; Galli M; Parravicini C
AIDS; 2004 May; 18(8):1224-6. PubMed ID: 15166546
[No Abstract] [Full Text] [Related]
6. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
Leitch H; Trudeau M; Routy JP
HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
[TBL] [Abstract][Full Text] [Related]
7. Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma.
Carleo MA; Di Martino F; Del Giudice A; Gargiulo M; Parrella G; Rosario P; Sangiovanni V; Viglietti R; Esposito V; Chirianni A
In Vivo; 2015; 29(1):133-6. PubMed ID: 25600542
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution inflammatory syndrome of Kaposi's sarcoma in an HIV-infected patient.
Lu CL; Chang SY; Tseng YT; Wu BR; Liu WC; Hsieh CY; Wu PY; Sun HY; Hung CC
J Microbiol Immunol Infect; 2013 Aug; 46(4):309-12. PubMed ID: 22503798
[TBL] [Abstract][Full Text] [Related]
9. AIDS related Kaposi's sarcoma presenting with palatal and eyelid nodule.
Joshi U; Ceena DE; Ongole R; Sumanth KN; Boaz K; Jeena Priy K; Srikan N
J Assoc Physicians India; 2012 Jul; 60():50-3. PubMed ID: 23405543
[TBL] [Abstract][Full Text] [Related]
10. Response to: a retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Maurer T; Leslie K; Unemori P
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):73. PubMed ID: 20484734
[No Abstract] [Full Text] [Related]
11. Intestinal Kaposi's sarcoma may mimic gastrointestinal stromal tumor in HIV infection.
Zoufaly A; Schmiedel S; Lohse A; van Lunzen J
World J Gastroenterol; 2007 Sep; 13(33):4514-6. PubMed ID: 17724811
[TBL] [Abstract][Full Text] [Related]
12. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
13. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
Loke WC; Spittle MF; Mitchell S; Kulasegaram R
Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
17. [HIV protease inhibitors for the treatment of Kaposi's sarcoma].
Grosso G; Sgadari C; Barillari G; Toschi E; Bacigalupo I; Carlei D; Palladino C; Baccarini S; Malavasi L; Moracci G; Leone P; Chiozzini C; Monini P; Ensoli B
Recenti Prog Med; 2003 Feb; 94(2):69-74. PubMed ID: 12908373
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage.
Tamm M; Reichenberger F; McGandy CE; Stalder A; Tietz A; Dalquen P; Perruchoud AP; Cathomas G
Am J Respir Crit Care Med; 1998 Feb; 157(2):458-63. PubMed ID: 9476858
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
Rizzieri DA; Liu J; Miralles D; Traweek ST
Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing Kaposi's sarcoma of the adrenal gland in an HIV-infected patient under antiretroviral therapy.
Castrejón N; Nicolau C; González-Cordón A; Archilla I; Solé M
Ann Diagn Pathol; 2019 Feb; 38():123-125. PubMed ID: 30580154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
